Yellow fever is an acute viral illness spread by mosquitoes, found in tropical regions of Africa and South America. Most people who catch it have mild symptoms or none at all, but about 15% develop a severe form that damages the liver and kidneys, killing roughly half of those who reach that stage. The disease gets its name from the jaundice (yellowing of the skin and eyes) that appears in serious cases.
What Causes Yellow Fever
The yellow fever virus belongs to the Flaviviridae family, the same group that includes dengue and Zika. It circulates through three distinct transmission cycles depending on where you are. In jungle areas, the virus passes between monkeys and forest mosquitoes, and humans get infected when they enter the forest for work or travel. In African savannah regions, an intermediate cycle exists where mosquitoes transmit the virus between monkeys and people, or between people, in communities near the jungle edge.
The urban cycle is the most dangerous from a public health standpoint. A person infected in the jungle or savannah travels to a city, where the common Aedes aegypti mosquito picks up the virus and spreads it from person to person. This is the same mosquito species responsible for dengue and Zika transmission, and it thrives in urban environments with standing water.
Where Yellow Fever Is Found
Yellow fever is endemic in 34 countries across sub-Saharan Africa and 13 countries in Central and South America. Africa carries the heaviest burden, accounting for roughly 90% of reported cases worldwide. The virus does not naturally circulate in Asia, though the Aedes aegypti mosquito is present there, which makes preventing international spread a global priority.
Many countries require proof of yellow fever vaccination for entry, particularly if you’re arriving from a region where the virus circulates. Some require it of all travelers regardless of origin. If you’re planning international travel to tropical regions, check the vaccination requirements for every country on your itinerary, including layover stops.
Symptoms and How the Disease Progresses
Yellow fever typically unfolds in two phases, though most people only experience the first. After an incubation period of three to six days, the initial phase brings on fever, muscle aches, headache, and nausea. These symptoms are nonspecific, meaning they look like dozens of other infections, which makes early diagnosis tricky. Most people recover after this stage and develop lifelong immunity.
About 15% of symptomatic patients enter a second, toxic phase. This is where yellow fever becomes dangerous. The fever returns, and the liver and kidneys begin to fail. Jaundice develops as the liver loses its ability to process bilirubin. Bleeding from the mouth, nose, or eyes can occur, along with blood in vomit or stool. Around 50% of patients who reach the toxic phase die, typically within 7 to 10 days. Overall case fatality rates vary widely, from 3% to as high as 70% depending on the setting and access to medical care, with the worst outcomes in patients with significant liver and kidney damage.
How It’s Diagnosed
Diagnosing yellow fever based on symptoms alone is unreliable because the early phase mimics so many other tropical infections, including dengue and malaria. Lab confirmation requires blood tests. In the first three to four days of illness, the virus itself can sometimes be detected in the blood using a PCR test. After the first week, that window closes and doctors look instead for antibodies the immune system produces in response to the virus.
One complication with antibody testing is cross-reactivity. If you’ve been exposed to related viruses like dengue or West Nile, your blood may test positive for yellow fever even when it isn’t the cause. More specific follow-up tests are needed to sort this out. A negative PCR result early in the illness also doesn’t rule out yellow fever, since the virus circulates in the blood only briefly.
Treatment Options
There is no antiviral drug that treats yellow fever. Care focuses entirely on managing symptoms and supporting the body while it fights the infection. For mild cases, that means rest, fluids, and medication to control fever and pain. One important detail: you should avoid aspirin, ibuprofen, and naproxen, because these can increase bleeding risk, which is already a concern with yellow fever.
Severe cases require hospitalization. Patients in the toxic phase need close monitoring of liver and kidney function, management of bleeding, and fluid support. Even with intensive care, the mortality rate in the toxic phase remains high. This is why prevention through vaccination is so critical.
The Yellow Fever Vaccine
The yellow fever vaccine is one of the most effective vaccines ever developed. Based on a live, weakened strain called 17D, it was first created in the 1930s and has been used billions of times since. A single dose protects more than 95% of recipients within 30 days. Neutralizing antibodies and immune memory cells have been detected in vaccinated people up to 60 years later, and since 2016, the World Health Organization has considered a single dose sufficient for lifelong protection. No booster is required.
The vaccine is not appropriate for everyone. Infants younger than 6 months should not receive it. Adults 60 and older face a slightly higher risk of rare but serious side effects, so the decision to vaccinate should weigh the actual risk of exposure. Pregnant and breastfeeding women fall into a precautionary category, as do people with weakened immune systems from conditions like symptomatic HIV, organ transplants, or immunosuppressive medications. If you fall into one of these groups and need to travel to an endemic area, a medical waiver letter can sometimes substitute for proof of vaccination at border crossings.
Global Efforts to End Epidemics
The World Health Organization, along with UNICEF and other partners, launched the Eliminate Yellow Fever Epidemics (EYE) strategy in 2017 with a target date of 2026. The strategy rests on three pillars: protecting at-risk populations through routine and mass vaccination campaigns, preventing international spread, and containing outbreaks rapidly when they occur. The goal is universal access to yellow fever immunization in every country where the virus poses a threat.
Affordable vaccine supply remains a challenge. Global stockpiles have been stretched thin during recent outbreaks, leading to the use of fractional dosing (one-fifth of a standard dose) during emergencies, which still provides strong short-term protection. Sustained political commitment and integration with other mosquito-borne disease programs are central to the strategy’s success.
Preventing Mosquito Bites
Vaccination is the strongest protection, but reducing mosquito exposure adds another layer of defense, especially in endemic areas. Wearing long sleeves and pants, using insect repellent containing DEET or picaridin, and sleeping under permethrin-treated bed nets all reduce your risk. Aedes aegypti mosquitoes bite primarily during daylight hours, so bed nets alone aren’t enough. Eliminating standing water around homes removes breeding sites for the mosquitoes that drive urban transmission.